Pictet Asset Management Portfolio holdings
AUM
$98.3B
1-Year Return
21%
This Quarter Return
+14.1%
1 Year Return
+21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$98.3B
AUM Growth
+$8.28B
(+9.2%)
Cap. Flow
-$1.44B
Cap. Flow
% of AUM
-1.46%
Top 10 Holdings %
Top 10 Hldgs %
19.88%
Holding
2,078
New
69
Increased
731
Reduced
969
Closed
78
Top Buys
| 1 |
AMRZ
Amrize Ltd
AMRZ
|
+$251M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$238M |
| 3 |
NVIDIA
NVDA
|
+$206M |
| 4 |
Dominion Energy
D
|
+$193M |
| 5 |
Spotify
SPOT
|
+$162M |
Top Sells
| 1 |
KLA
KLAC
|
+$213M |
| 2 |
Zscaler
ZS
|
+$188M |
| 3 |
Republic Services
RSG
|
+$185M |
| 4 |
ANSS
Ansys
ANSS
|
+$185M |
| 5 |
Informatica
INFA
|
+$182M |
Sector Composition
| 1 | Technology | 34.74% |
| 2 | Industrials | 16.05% |
| 3 | Healthcare | 11.57% |
| 4 | Financials | 8.09% |
| 5 | Consumer Discretionary | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Moderna
MRNA
$9.45B
| $18.6M | 0.02% |
682,499
+2,751
| +0.4% | +$74.8K |
|
527
Ross Stores
ROST
$48.8B
| $18.5M | 0.02% |
145,119
+5,068
| +4% | +$647K |
|
528
LPL Financial
LPLA
$27.4B
| $18.4M | 0.02% |
49,182
+2,646
| +6% | +$992K |
|
529
W.R. Berkley
WRB
$27.4B
| $18.4M | 0.02% |
250,951
-23,356
| -9% | -$1.72M |
|
530
General Mills
GIS
$26.7B
| $18.4M | 0.02% |
355,165
-9,315
| -3% | -$483K |
|
531
Seagate
STX
$41.1B
| $18.3M | 0.02% |
127,115
+4,588
| +4% | +$662K |
|
532
Vera Therapeutics
VERA
$1.56B
| $18.2M | 0.02% |
772,814
-67,444
| -8% | -$1.59M |
|
533
Trade Desk
TTD
$22.6B
| $18M | 0.02% |
249,931
+19,156
| +8% | +$1.38M |
|
534
Krystal Biotech
KRYS
$3.98B
| $17.9M | 0.02% |
130,537
+65,275
| +100% | +$8.97M |
|
535
Grifois
GRFS
$6.7B
| $17.9M | 0.02% |
1,988,393
-151,964
| -7% | -$1.37M |
|
536
Carvana
CVNA
$50.4B
| $17.7M | 0.02% |
52,647
+8,175
| +18% | +$2.75M |
|
537
Viridian Therapeutics
VRDN
$1.62B
| $17.7M | 0.02% |
1,265,754
+17,033
| +1% | +$238K |
|
538
Flutter Entertainment
FLUT
$51.2B
| $17.7M | 0.02% |
61,848
+2,399
| +4% | +$686K |
|
539
Fortive
FTV
$16.2B
| $17.6M | 0.02% |
335,719
+117,885
| +54% | +$6.17M |
|
540
Royalty Pharma
RPRX
$15.6B
| $17.5M | 0.02% |
486,140
+120,930
| +33% | +$4.35M |
|
541
Dover
DOV
$24.1B
| $17.4M | 0.02% |
94,752
+6,979
| +8% | +$1.28M |
|
542
Rollins
ROL
$27.3B
| $17.4M | 0.02% |
307,695
+64,467
| +27% | +$3.64M |
|
543
ResMed
RMD
$39.6B
| $17.3M | 0.02% |
67,105
-1,817
| -3% | -$469K |
|
544
Supernus Pharmaceuticals
SUPN
$2.59B
| $17.3M | 0.02% |
554,482
+10,569
| +2% | +$329K |
|
545
Keysight
KEYS
$29.3B
| $17.2M | 0.02% |
105,210
+1,626
| +2% | +$266K |
|
546
Ingevity
NGVT
$2.08B
| $17.2M | 0.02% |
398,696
+58,535
| +17% | +$2.52M |
|
547
Mineralys Therapeutics
MLYS
$2.99B
| $17.2M | 0.02% |
1,267,993
+53,620
| +4% | +$725K |
|
548
CGI
GIB
$20.7B
| $17.1M | 0.02% |
163,298
-11,255
| -6% | -$1.18M |
|
549
Northern Trust
NTRS
$24.2B
| $17.1M | 0.02% |
134,805
-8,322
| -6% | -$1.06M |
|
550
Novanta
NOVT
$4.14B
| $17.1M | 0.02% |
132,350
-317
| -0.2% | -$40.9K |
|